Newton Biocapital logo

Newton Biocapital

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Description

Newton Biocapital is a venture capital investment fund that invests in the life sciences sector with a specialization in chronic diseases.

Investor Profile

Newton Biocapital has made 20 investments, with 3 in the past 12 months and 65% as lead.

Stage Focus

  • Series A (35%)
  • Series Unknown (25%)
  • Series B (15%)
  • Seed (15%)
  • Series D (10%)

Country Focus

  • Belgium (40%)
  • France (30%)
  • Japan (25%)
  • Switzerland (5%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Medical Device
  • Health Care
  • Oncology
  • Biopharma
  • Therapeutics
  • Nursing And Residential Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Newton Biocapital frequently co-invest with?

QB Capital
Asia, Fukuoka, Japan, Fukuoka
Co-Investments: 2
Sambrinvest
Europe, Hainaut, Belgium, Gosselies
Co-Investments: 4
CM
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 2
Investsud
Europe, Luxembourg, Belgium, Marche-en-famenne
Co-Investments: 2
S
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussel
Co-Investments: 2
Co-Investments: 2
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 4
PMV
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 2

Which angels does Newton Biocapital often collaborate with?

PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Newton Biocapital?

Augustine Therapeutics

Leuven, Vlaams-Brabant, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

BiopharmaBiotechnologyPharmaceutical
Series AMar 24, 2025
Amount Raised: $84,139,626
Tensegrity Pharma

Tokyo, Tokyo, Japan

Tensegrity Pharma is the developer of a novel drug designed to minimize bottlenecks and provide innovative value to patients.

Clinical TrialsMedicalPharmaceutical
SeedNov 13, 2024
Amount Raised: $3,216,924
AdipoPharma

Illkirch-graffenstaden, Alsace, France

AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes.

BiotechnologyMedicalPharmaceutical
Series UnknownNov 11, 2024
AbolerIS Pharma

Nantes, Pays de la Loire, France

AbolerIS Pharma develops immuno-modulators as treatments for transplant rejection, graft-versus-host disease, and auto-immune diseases.

Biotechnology
Series ASep 19, 2023
Amount Raised: $29,160,405
Santero Therapeutics

Charleroi, Hainaut, Belgium

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

BiotechnologyHealth CareTherapeutics
Series AJun 8, 2023
Amount Raised: $8,625,644
AdipoPharma

Illkirch-graffenstaden, Alsace, France

AdipoPharma SAS is dedicated to learning more about the role of adipocyte cells in diabetes.

BiotechnologyMedicalPharmaceutical
Series AJan 23, 2023
DeuterOncology

Geel, Antwerpen, Belgium

DeuterOncology is a preclinical-stage biotech company.

BiotechnologyMedicalOncology
Series AJan 19, 2023
Amount Raised: $6,120,926
NeuVasQ

Gosselies, Hainaut, Belgium

NeuVasQ is a pharmaceutical restoration company.

BiotechnologyMedicalPharmaceutical
Series AJun 24, 2021
Amount Raised: $23,856,441
EditForce

Fukuoka, Fukuoka, Japan

EditForce develops drugs and seeds by using nucleic acid manipulation technologies.

BiotechnologyMedicalNursing and Residential Care
Series UnknownMay 26, 2021
Amount Raised: $7,327,953
DeuterOncology

Geel, Antwerpen, Belgium

DeuterOncology is a preclinical-stage biotech company.

BiotechnologyMedicalOncology
SeedFeb 24, 2021